Allergic & Immune-Mediated Conjunctivitis

Immunopathogenesis & Clinical Clues

Allergic conjunctivitis results from a Type I (IgE-mediated) hypersensitivity reaction: allergen cross-linking of IgE bound to conjunctival mast cells triggers degranulation and release of histamine and other inflammatory mediators. Histamine binds H1 receptors on conjunctival nerve endings and vasculature, producing the itching and vasodilation that define the presentation.

Allergic conjunctivitis reflects a systemic response to environmental allergens reaching both eyes at once, so it is typically bilateral and symmetric from onset. Infectious conjunctivitis, by contrast, often starts unilaterally before spreading. Itching is the predominant complaint, and that bilateral, itchy pattern is the most specific clinical clue to an allergic cause; watery discharge and foreign-body sensation occur in viral disease too, but intense itch favors allergy. Conjunctival cytology supports the diagnosis directly when obtained: a Giemsa-stained scraping dominated by eosinophils is the hallmark of allergic conjunctivitis, as opposed to the neutrophils of bacterial conjunctivitis or the mononuclear cells and lymphocytes seen in viral disease.

Pharmacotherapy

First-line symptomatic treatment is a dual-acting topical antihistamine/mast-cell stabilizer (olopatadine, ketotifen, azelastine, and similar agents). The antihistamine component relieves itching quickly; the mast-cell-stabilizing component blocks further degranulation, giving both immediate relief and a mechanism for ongoing control. That combination is why these agents work as daily maintenance therapy in patients with recurrent or seasonal disease, not just as an as-needed rescue.

Vernal Keratoconjunctivitis

Vernal keratoconjunctivitis (VKC) is a severe, chronic form of allergic conjunctival disease. It classically affects young males with a personal or family history of atopy (asthma, eczema, allergic rhinitis), is more common in warm, dry climates, and often worsens seasonally.

Its defining exam finding is giant papillae: large, flat-topped papillae greater than 1 mm in diameter arranged in a "cobblestone" pattern on the upper tarsal conjunctiva. This is a far more dramatic papillary reaction than the fine papillae seen in ordinary bacterial or allergic conjunctivitis.

Shield Ulcer

Chronic VKC carries a vision-threatening complication that sets it apart from garden-variety allergic conjunctivitis: the shield ulcer, a sterile, well-demarcated corneal epithelial defect with an overlying plaque. It results from chronic mechanical trauma by the giant papillae combined with toxic mediators released by eosinophils, and left unaddressed it can progress to corneal scarring and vision loss.

Steroid-Sparing Therapy

For severe itching and giant papillae refractory to antihistamines, topical cyclosporine A is commonly added. It inhibits T-cell-mediated inflammation and acts as a steroid-sparing agent in chronic severe allergic disease like VKC, cutting the long-term corticosteroid exposure that would otherwise be needed to keep it controlled.

Atopic Keratoconjunctivitis

Atopic keratoconjunctivitis (AKC) is easy to confuse with VKC: both are itchy, papillary, and tied to a personal history of atopy. The two diverge in who gets them and how they behave. AKC typically presents in adults aged 20 to 50 with established atopic dermatitis and runs a perennial, chronic course that can progress to conjunctival scarring and cicatrization. VKC instead favors children and teenagers, flares seasonally, and usually resolves around puberty without lasting conjunctival damage.

Giant Papillary Conjunctivitis

Giant papillary conjunctivitis (GPC) is best understood as a mechanical and immune-mediated hypersensitivity process, not a purely allergic or infectious one. Chronic mechanical irritation, most often from contact lenses but also from ocular prostheses or exposed sutures, layers onto an immune-mediated response and produces a giant-papillae picture that can resemble VKC. GPC is overwhelmingly a contact-lens-wear phenomenon in practice, so its full clinical picture and management belong with contact lens disease; see Contact Lens-Related Corneal Disease for that depth.

Other Exam Findings

Two exam findings are worth knowing independent of any single diagnosis, since they can accompany either severe allergic or severe infectious conjunctivitis rather than pointing to one specific cause:

A pseudomembrane is a membrane of fibrin and inflammatory cells adherent to, but not invading, the epithelium. It can be peeled from the conjunctival surface without bleeding, and is seen in severe bacterial or adenoviral conjunctivitis. This distinguishes it from a true membrane, which is more adherent and bleeds on removal.

Chemosis refers to conjunctival edema from increased vascular permeability, giving the conjunctiva a translucent, gelatinous, swollen appearance. It is common in allergic conjunctivitis but also occurs in severe inflammatory conjunctivitis of other causes.

Related Topics

Continue exploring Cornea & External Disease: